Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · IEX Real-Time Price · USD
1.660
-0.040 (-2.35%)
At close: Apr 24, 2024, 4:00 PM
1.630
-0.030 (-1.81%)
After-hours: Apr 24, 2024, 7:17 PM EDT

Milestone Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Revenue
15150000
Revenue Growth (YoY)
-80.00%-66.67%-----
Gross Profit
15150000
Selling, General & Admin
15.9315.7212.410.2973.052.63
Research & Development
31.0539.8338.6734.4941.9916.855.64
Other Operating Expenses
15.119.175.948.893.920
Operating Expenses
62.164.6458.0750.7157.8823.828.27
Operating Income
-61.1-59.64-43.07-50.71-57.88-23.82-8.27
Interest Expense / Income
2.55000000
Other Expense / Income
-3.97-1.25-0.22-0.73-2.6-0.71-0.19
Pretax Income
-59.69-58.39-42.85-49.98-55.29-23.11-8.08
Income Tax
000-0.02-0.060.070
Net Income
-59.69-58.39-42.85-49.97-55.23-23.19-8.09
Shares Outstanding (Basic)
434242291600
Shares Outstanding (Diluted)
434242291600
Shares Change
1.19%1.47%42.56%85.91%4845.07%34.83%-
EPS (Basic)
-1.39-1.38-1.02-1.70-3.50-72.63-34.15
EPS (Diluted)
-1.39-1.38-1.02-1.70-3.50-72.63-34.15
Free Cash Flow
-46.54-52.74-33.22-50.73-51.57-21.05-8.09
Free Cash Flow Per Share
-1.08-1.24-0.79-1.73-3.27-65.95-34.16
Gross Margin
100.00%100.00%100.00%----
Operating Margin
-6109.80%-1192.84%-287.15%----
Profit Margin
-5968.50%-1167.76%-285.69%----
Free Cash Flow Margin
-4653.60%-1054.82%-221.49%----
EBITDA
-57.04-58.3-42.76-49.89-55.25-23.1-8.07
EBITDA Margin
-5703.90%-1165.98%-285.07%----
Depreciation & Amortization
0.090.090.090.10.040.010.01
EBIT
-57.13-58.39-42.85-49.98-55.29-23.11-8.08
EBIT Margin
-5713.10%-1167.76%-285.69%----
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).